Document is current
Any future updates will be listed below
-
Authors
Broome, Sophie C. https://orcid.org/0000-0002-4163-7847
Whitfield, Jamie https://orcid.org/0000-0002-8961-8872
Karagounis, Leonidas G. https://orcid.org/0000-0003-2403-3387
Hawley, John A. https://orcid.org/0000-0002-0886-9881
-
Funding
Funding for this research was provided by:
Australian Catholic University Limited
- License Information
-
More Information
Article History
Accepted: 28 June 2024
First Online: 26 July 2024
Declarations
:
: In the interest of full disclosure, SCB reports gifts from MitoQ Ltd. who manufacture MitoQ. JAH reports research funding received from Amazentis Inc. who manufacture the urolithin A supplement Mitopure. JW has received conference and travel support from Amazentis Inc. LGK was an employee of Nestlé Research and Nestlé Health Science and reports personal fees from Nestlé Health Science who manufacture n3-PUFAs, urolithin A, GlyNAC, and nicotinamide riboside including multivitamins such as B6 and B3.
: SCB, JW, LGK and JAH formulated the research questions. SCB and JW conducted the literature search. Figures and tables were prepared by SCB, JW and JAH. SCB wrote the manuscript with critical input from JW, LGK, and JAH. All authors read and approved the final version of the manuscript.
